ÂÜÀòÂÒÂ×

Deborah S. Kelly M.D. serves as the Division Vice President at Incyte since July 2020, with a focus on Global Risk Management and Safety Surveillance in previous roles as Associate Vice President and Executive Medical Director. Prior experience includes serving as Senior Medical Director at Aclaris Therapeutics, Inc. and Head of Pharmacovigilance at Spark Therapeutics, Inc. Additionally, Deborah contributed to academia as an Adjunct Assistant Professor at the Scheie Eye Institute and held multiple roles at GlaxoSmithKline, including Medical Director in Safety Evaluation and Ophthalmology R&D. Deborah's educational background includes a degree in Molecular Biophysics & Biochemistry from Yale University and a medical degree from Columbia University, followed by residency training at Emory University School of Medicine.